PubMed:9341756
Annnotations
Inflammaging
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T1 | 0-189 | Sentence | denotes | Induction of endothelial cell surface adhesion molecules by tumor necrosis factor is blocked by protein tyrosine phosphatase inhibitors: role of the nuclear transcription factor NF-kappa B. |
| T2 | 190-466 | Sentence | denotes | Recent studies from our laboratory have indicated that protein tyrosine phosphatase (PTPase) inhibitors can down-modulate the tumor necrosis factor (TNF)-mediated activation of the nuclear transcription factor NF-kappa B in ML-1a, a monocytic cell line (Singh and Aggarwal, J. |
| T3 | 467-472 | Sentence | denotes | Biol. |
| T4 | 473-478 | Sentence | denotes | Chem. |
| T5 | 479-484 | Sentence | denotes | 1995: |
| T6 | 485-489 | Sentence | denotes | 270: |
| T7 | 490-497 | Sentence | denotes | 10631). |
| T8 | 498-878 | Sentence | denotes | Since TNF is one of the major inducers of various adhesion molecules in human endothelial cells and their expression is known to require the activation of NF-kappa B, we examined the effect of PTPase inhibitors on the TNF-mediated induction of intracellular adhesion molecule (ICAM)-1, vascular cell adhesion molecule (VCAM)-1 and endothelial leukocyte adhesion molecule (ELAM)-1. |
| T9 | 879-1119 | Sentence | denotes | Like ML-1a, human dermal microvessel endothelial cells (MVEC) treated with TNF rapidly activated (within 30 min) NF-kappa B; this effect was completely abolished by co-treatment with phenylarsine oxide (PAO), a specific inhibitor of PTPase. |
| T10 | 1120-1272 | Sentence | denotes | The induction of ICAM-1, VCAM-1, and ELAM-1 by TNF in MVEC occurred within 6 h and was also completely down-regulated by PAO in a dose-dependent manner. |
| T11 | 1273-1386 | Sentence | denotes | PAO was found to be effective even when added 3 h after TNF, suggesting a rapid mode of action of this inhibitor. |
| T12 | 1387-1561 | Sentence | denotes | Besides PAO, other inhibitors of PTPase, including pervanadate and diamide, also blocked TNF-dependent NF-kappa B activation and induction of all the three adhesion proteins. |
| T13 | 1562-1671 | Sentence | denotes | Consistent with these results, the attachment of monocytes to MVEC was also blocked by the PTPase inhibitors. |
| T14 | 1672-1853 | Sentence | denotes | Thus, overall, our results demonstrate that a PTPase is involved either directly or indirectly in the pathway leading to the induction of endothelial cell adhesion molecules by TNF. |
| T15 | 1854-2015 | Sentence | denotes | Because of their role in cell adhesion, PTPase may provide a novel target of drug development for treatment of inflammation, atherogenesis, and tumor metastasis. |
| T1 | 0-189 | Sentence | denotes | Induction of endothelial cell surface adhesion molecules by tumor necrosis factor is blocked by protein tyrosine phosphatase inhibitors: role of the nuclear transcription factor NF-kappa B. |
| T2 | 190-466 | Sentence | denotes | Recent studies from our laboratory have indicated that protein tyrosine phosphatase (PTPase) inhibitors can down-modulate the tumor necrosis factor (TNF)-mediated activation of the nuclear transcription factor NF-kappa B in ML-1a, a monocytic cell line (Singh and Aggarwal, J. |
| T3 | 467-472 | Sentence | denotes | Biol. |
| T4 | 473-478 | Sentence | denotes | Chem. |
| T5 | 479-484 | Sentence | denotes | 1995: |
| T6 | 485-489 | Sentence | denotes | 270: |
| T7 | 490-497 | Sentence | denotes | 10631). |
| T8 | 498-878 | Sentence | denotes | Since TNF is one of the major inducers of various adhesion molecules in human endothelial cells and their expression is known to require the activation of NF-kappa B, we examined the effect of PTPase inhibitors on the TNF-mediated induction of intracellular adhesion molecule (ICAM)-1, vascular cell adhesion molecule (VCAM)-1 and endothelial leukocyte adhesion molecule (ELAM)-1. |
| T9 | 879-1119 | Sentence | denotes | Like ML-1a, human dermal microvessel endothelial cells (MVEC) treated with TNF rapidly activated (within 30 min) NF-kappa B; this effect was completely abolished by co-treatment with phenylarsine oxide (PAO), a specific inhibitor of PTPase. |
| T10 | 1120-1272 | Sentence | denotes | The induction of ICAM-1, VCAM-1, and ELAM-1 by TNF in MVEC occurred within 6 h and was also completely down-regulated by PAO in a dose-dependent manner. |
| T11 | 1273-1386 | Sentence | denotes | PAO was found to be effective even when added 3 h after TNF, suggesting a rapid mode of action of this inhibitor. |
| T12 | 1387-1561 | Sentence | denotes | Besides PAO, other inhibitors of PTPase, including pervanadate and diamide, also blocked TNF-dependent NF-kappa B activation and induction of all the three adhesion proteins. |
| T13 | 1562-1671 | Sentence | denotes | Consistent with these results, the attachment of monocytes to MVEC was also blocked by the PTPase inhibitors. |
| T14 | 1672-1853 | Sentence | denotes | Thus, overall, our results demonstrate that a PTPase is involved either directly or indirectly in the pathway leading to the induction of endothelial cell adhesion molecules by TNF. |
| T15 | 1854-2015 | Sentence | denotes | Because of their role in cell adhesion, PTPase may provide a novel target of drug development for treatment of inflammation, atherogenesis, and tumor metastasis. |
jnlpba-st-training
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T1 | 13-56 | protein | denotes | endothelial cell surface adhesion molecules |
| T2 | 60-81 | protein | denotes | tumor necrosis factor |
| T3 | 149-188 | protein | denotes | nuclear transcription factor NF-kappa B |
| T4 | 245-273 | protein | denotes | protein tyrosine phosphatase |
| T5 | 275-281 | protein | denotes | PTPase |
| T6 | 316-337 | protein | denotes | tumor necrosis factor |
| T7 | 339-342 | protein | denotes | TNF |
| T8 | 371-410 | protein | denotes | nuclear transcription factor NF-kappa B |
| T9 | 414-419 | cell_line | denotes | ML-1a |
| T10 | 423-442 | cell_line | denotes | monocytic cell line |
| T11 | 504-507 | protein | denotes | TNF |
| T12 | 548-566 | protein | denotes | adhesion molecules |
| T13 | 653-663 | protein | denotes | NF-kappa B |
| T14 | 691-697 | protein | denotes | PTPase |
| T15 | 716-719 | protein | denotes | TNF |
| T16 | 742-782 | protein | denotes | intracellular adhesion molecule (ICAM)-1 |
| T17 | 784-824 | protein | denotes | vascular cell adhesion molecule (VCAM)-1 |
| T18 | 829-877 | protein | denotes | endothelial leukocyte adhesion molecule (ELAM)-1 |
| T19 | 884-889 | cell_line | denotes | ML-1a |
| T20 | 891-933 | cell_line | denotes | human dermal microvessel endothelial cells |
| T21 | 935-939 | cell_line | denotes | MVEC |
| T22 | 954-957 | protein | denotes | TNF |
| T23 | 992-1002 | protein | denotes | NF-kappa B |
| T24 | 1112-1118 | protein | denotes | PTPase |
| T25 | 1137-1143 | protein | denotes | ICAM-1 |
| T26 | 1145-1151 | protein | denotes | VCAM-1 |
| T27 | 1157-1163 | protein | denotes | ELAM-1 |
| T28 | 1167-1170 | protein | denotes | TNF |
| T29 | 1174-1178 | cell_line | denotes | MVEC |
| T30 | 1329-1332 | protein | denotes | TNF |
| T31 | 1420-1426 | protein | denotes | PTPase |
| T32 | 1476-1479 | protein | denotes | TNF |
| T33 | 1490-1500 | protein | denotes | NF-kappa B |
| T34 | 1543-1560 | protein | denotes | adhesion proteins |
| T35 | 1624-1628 | cell_line | denotes | MVEC |
| T36 | 1653-1659 | protein | denotes | PTPase |
| T37 | 1718-1724 | protein | denotes | PTPase |
| T38 | 1810-1845 | protein | denotes | endothelial cell adhesion molecules |
| T39 | 1849-1852 | protein | denotes | TNF |
| T40 | 1894-1900 | protein | denotes | PTPase |
pubmed-sentences-benchmark
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| S1 | 0-189 | Sentence | denotes | Induction of endothelial cell surface adhesion molecules by tumor necrosis factor is blocked by protein tyrosine phosphatase inhibitors: role of the nuclear transcription factor NF-kappa B. |
| S2 | 190-497 | Sentence | denotes | Recent studies from our laboratory have indicated that protein tyrosine phosphatase (PTPase) inhibitors can down-modulate the tumor necrosis factor (TNF)-mediated activation of the nuclear transcription factor NF-kappa B in ML-1a, a monocytic cell line (Singh and Aggarwal, J. Biol. Chem. 1995: 270: 10631). |
| S3 | 498-878 | Sentence | denotes | Since TNF is one of the major inducers of various adhesion molecules in human endothelial cells and their expression is known to require the activation of NF-kappa B, we examined the effect of PTPase inhibitors on the TNF-mediated induction of intracellular adhesion molecule (ICAM)-1, vascular cell adhesion molecule (VCAM)-1 and endothelial leukocyte adhesion molecule (ELAM)-1. |
| S4 | 879-1119 | Sentence | denotes | Like ML-1a, human dermal microvessel endothelial cells (MVEC) treated with TNF rapidly activated (within 30 min) NF-kappa B; this effect was completely abolished by co-treatment with phenylarsine oxide (PAO), a specific inhibitor of PTPase. |
| S5 | 1120-1272 | Sentence | denotes | The induction of ICAM-1, VCAM-1, and ELAM-1 by TNF in MVEC occurred within 6 h and was also completely down-regulated by PAO in a dose-dependent manner. |
| S6 | 1273-1386 | Sentence | denotes | PAO was found to be effective even when added 3 h after TNF, suggesting a rapid mode of action of this inhibitor. |
| S7 | 1387-1561 | Sentence | denotes | Besides PAO, other inhibitors of PTPase, including pervanadate and diamide, also blocked TNF-dependent NF-kappa B activation and induction of all the three adhesion proteins. |
| S8 | 1562-1671 | Sentence | denotes | Consistent with these results, the attachment of monocytes to MVEC was also blocked by the PTPase inhibitors. |
| S9 | 1672-1853 | Sentence | denotes | Thus, overall, our results demonstrate that a PTPase is involved either directly or indirectly in the pathway leading to the induction of endothelial cell adhesion molecules by TNF. |
| S10 | 1854-2015 | Sentence | denotes | Because of their role in cell adhesion, PTPase may provide a novel target of drug development for treatment of inflammation, atherogenesis, and tumor metastasis. |
genia-medco-coref
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| C1 | 60-81 | NP | denotes | tumor necrosis factor |
| C2 | 96-135 | NP | denotes | protein tyrosine phosphatase inhibitors |
| C3 | 145-188 | NP | denotes | the nuclear transcription factor NF-kappa B |
| C4 | 245-293 | NP | denotes | protein tyrosine phosphatase (PTPase) inhibitors |
| C5 | 367-410 | NP | denotes | the nuclear transcription factor NF-kappa B |
| C6 | 414-419 | NP | denotes | ML-1a |
| C7 | 421-442 | NP | denotes | a monocytic cell line |
| C8 | 504-507 | NP | denotes | TNF |
| C9 | 540-593 | NP | denotes | various adhesion molecules in human endothelial cells |
| C10 | 598-603 | NP | denotes | their |
| C11 | 653-663 | NP | denotes | NF-kappa B |
| C12 | 691-708 | NP | denotes | PTPase inhibitors |
| C13 | 742-877 | NP | denotes | intracellular adhesion molecule (ICAM)-1, vascular cell adhesion molecule (VCAM)-1 and endothelial leukocyte adhesion molecule (ELAM)-1 |
| C14 | 884-889 | NP | denotes | ML-1a |
| C15 | 954-957 | NP | denotes | TNF |
| C16 | 992-1003 | NP | denotes | NF-kappa B; |
| C17 | 1062-1086 | NP | denotes | phenylarsine oxide (PAO) |
| C19 | 1112-1118 | NP | denotes | PTPase |
| C18 | 1088-1118 | NP | denotes | a specific inhibitor of PTPase |
| C20 | 1137-1163 | NP | denotes | ICAM-1, VCAM-1, and ELAM-1 |
| C21 | 1174-1178 | NP | denotes | MVEC |
| C22 | 1241-1244 | NP | denotes | PAO |
| C23 | 1273-1276 | NP | denotes | PAO |
| C24 | 1329-1332 | NP | denotes | TNF |
| C25 | 1371-1385 | NP | denotes | this inhibitor |
| C26 | 1395-1398 | NP | denotes | PAO |
| C27 | 1420-1426 | NP | denotes | PTPase |
| C28 | 1529-1560 | NP | denotes | all the three adhesion proteins |
| C29 | 1624-1628 | NP | denotes | MVEC |
| C30 | 1649-1670 | NP | denotes | the PTPase inhibitors |
| C31 | 1716-1724 | NP | denotes | a PTPase |
| C32 | 1849-1852 | NP | denotes | TNF |
| C33 | 1865-1870 | NP | denotes | their |
| C34 | 1894-1900 | NP | denotes | PTPase |
| R1 | C4 | C2 | coref-ident | protein tyrosine phosphatase (PTPase) inhibitors,protein tyrosine phosphatase inhibitors |
| R2 | C5 | C3 | coref-ident | the nuclear transcription factor NF-kappa B,the nuclear transcription factor NF-kappa B |
| R3 | C7 | C6 | coref-appos | a monocytic cell line,ML-1a |
| R4 | C8 | C1 | coref-ident | TNF,tumor necrosis factor |
| R5 | C10 | C9 | coref-pron | their,various adhesion molecules in human endothelial cells |
| R6 | C11 | C5 | coref-ident | NF-kappa B,the nuclear transcription factor NF-kappa B |
| R7 | C12 | C4 | coref-ident | PTPase inhibitors,protein tyrosine phosphatase (PTPase) inhibitors |
| R8 | C14 | C6 | coref-ident | ML-1a,ML-1a |
| R9 | C15 | C8 | coref-ident | TNF,TNF |
| R10 | C16 | C11 | coref-ident | NF-kappa B;,NF-kappa B |
| R11 | C18 | C17 | coref-appos | a specific inhibitor of PTPase,phenylarsine oxide (PAO) |
| R12 | C20 | C13 | coref-ident | "ICAM-1, VCAM-1, and ELAM-1","intracellular adhesion molecule (ICAM)-1, vascular cell adhesion molecule (VCAM)-1 and endothelial leukocyte adhesion molecule (ELAM)-1" |
| R13 | C22 | C17 | coref-ident | PAO,phenylarsine oxide (PAO) |
| R14 | C23 | C22 | coref-ident | PAO,PAO |
| R15 | C24 | C15 | coref-ident | TNF,TNF |
| R16 | C25 | C23 | coref-ident | this inhibitor,PAO |
| R17 | C26 | C25 | coref-ident | PAO,this inhibitor |
| R18 | C27 | C19 | coref-ident | PTPase,PTPase |
| R19 | C28 | C20 | coref-ident | all the three adhesion proteins,"ICAM-1, VCAM-1, and ELAM-1" |
| R20 | C29 | C21 | coref-ident | MVEC,MVEC |
| R21 | C30 | C12 | coref-ident | the PTPase inhibitors,PTPase inhibitors |
| R22 | C31 | C27 | coref-ident | a PTPase,PTPase |
| R23 | C32 | C24 | coref-ident | TNF,TNF |
| R24 | C33 | C31 | coref-pron | their,a PTPase |
| R25 | C34 | C31 | coref-ident | PTPase,a PTPase |
GENIAcorpus
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T1 | 13-56 | protein_family_or_group | denotes | endothelial cell surface adhesion molecules |
| T2 | 60-81 | protein_family_or_group | denotes | tumor necrosis factor |
| T3 | 104-112 | amino_acid_monomer | denotes | tyrosine |
| T4 | 113-135 | other_organic_compound | denotes | phosphatase inhibitors |
| T5 | 149-156 | protein_complex | denotes | nuclear |
| T6 | 157-177 | protein_family_or_group | denotes | transcription factor |
| T7 | 178-188 | protein_complex | denotes | NF-kappa B |
| T8 | 245-273 | protein_molecule | denotes | protein tyrosine phosphatase |
| T9 | 275-281 | protein_molecule | denotes | PTPase |
| T10 | 316-337 | protein_family_or_group | denotes | tumor necrosis factor |
| T11 | 339-342 | protein_family_or_group | denotes | TNF |
| T12 | 371-410 | protein_complex | denotes | nuclear transcription factor NF-kappa B |
| T13 | 414-419 | cell_line | denotes | ML-1a |
| T14 | 423-442 | cell_line | denotes | monocytic cell line |
| T15 | 504-507 | protein_family_or_group | denotes | TNF |
| T16 | 548-566 | protein_family_or_group | denotes | adhesion molecules |
| T17 | 653-663 | protein_complex | denotes | NF-kappa B |
| T18 | 691-697 | protein_family_or_group | denotes | PTPase |
| T19 | 716-719 | protein_family_or_group | denotes | TNF |
| T20 | 742-782 | protein_molecule | denotes | intracellular adhesion molecule (ICAM)-1 |
| T21 | 784-824 | protein_molecule | denotes | vascular cell adhesion molecule (VCAM)-1 |
| T22 | 829-877 | protein_molecule | denotes | endothelial leukocyte adhesion molecule (ELAM)-1 |
| T23 | 884-889 | cell_line | denotes | ML-1a |
| T24 | 891-933 | cell_line | denotes | human dermal microvessel endothelial cells |
| T25 | 935-939 | cell_line | denotes | MVEC |
| T26 | 954-957 | protein_family_or_group | denotes | TNF |
| T27 | 992-1002 | protein_complex | denotes | NF-kappa B |
| T28 | 1062-1080 | other_organic_compound | denotes | phenylarsine oxide |
| T29 | 1082-1085 | other_organic_compound | denotes | PAO |
| T30 | 1112-1118 | protein_family_or_group | denotes | PTPase |
| T31 | 1137-1143 | protein_molecule | denotes | ICAM-1 |
| T32 | 1145-1151 | protein_molecule | denotes | VCAM-1 |
| T33 | 1157-1163 | protein_molecule | denotes | ELAM-1 |
| T34 | 1167-1170 | protein_family_or_group | denotes | TNF |
| T35 | 1174-1178 | cell_line | denotes | MVEC |
| T36 | 1241-1244 | other_organic_compound | denotes | PAO |
| T37 | 1273-1276 | other_organic_compound | denotes | PAO |
| T38 | 1329-1332 | protein_family_or_group | denotes | TNF |
| T39 | 1395-1398 | other_organic_compound | denotes | PAO |
| T40 | 1420-1426 | protein_family_or_group | denotes | PTPase |
| T41 | 1438-1449 | other_organic_compound | denotes | pervanadate |
| T42 | 1476-1479 | protein_family_or_group | denotes | TNF |
| T43 | 1490-1500 | protein_complex | denotes | NF-kappa B |
| T44 | 1543-1560 | protein_family_or_group | denotes | adhesion proteins |
| T45 | 1624-1628 | cell_line | denotes | MVEC |
| T46 | 1653-1659 | protein_family_or_group | denotes | PTPase |
| T47 | 1718-1724 | protein_family_or_group | denotes | PTPase |
| T48 | 1810-1826 | protein_family_or_group | denotes | endothelial cell |
| T49 | 1827-1845 | protein_family_or_group | denotes | adhesion molecules |
| T50 | 1849-1852 | protein_family_or_group | denotes | TNF |
| T51 | 1879-1892 | other_name | denotes | cell adhesion |
| T52 | 1894-1900 | protein_family_or_group | denotes | PTPase |
| T53 | 1965-1977 | other_name | denotes | inflammation |
| T54 | 1979-1992 | other_name | denotes | atherogenesis |
| T55 | 1998-2014 | other_name | denotes | tumor metastasis |